| Autor: |
Avchalumov Y; Veterans Affairs San Diego Healthcare System, San Diego, CA 92161, USA., Kreisler AD; Veterans Affairs San Diego Healthcare System, San Diego, CA 92161, USA., Trenet W; Veterans Affairs San Diego Healthcare System, San Diego, CA 92161, USA., Nayak M; Veterans Affairs San Diego Healthcare System, San Diego, CA 92161, USA., Head BP; Veterans Affairs San Diego Healthcare System, San Diego, CA 92161, USA.; Department of Anesthesiology, University of California San Diego, San Diego, CA 92037, USA., Piña-Crespo JC; Department of Molecular Medicine, Scripps Research, La Jolla, CA 92037, USA., Mandyam CD; Veterans Affairs San Diego Healthcare System, San Diego, CA 92161, USA.; Department of Anesthesiology, University of California San Diego, San Diego, CA 92037, USA. |
| Abstrakt: |
Dopamine D1 receptor (D1R) function is regulated by membrane/lipid raft-resident protein caveolin-1 (Cav1). We examined whether altered expression of Cav1 in the dorsal striatum would affect self-administration of methamphetamine, an indirect agonist at the D1Rs. A lentiviral construct expressing Cav1 (LV-Cav1) or containing a short hairpin RNA against Cav1 (LV-shCav1) was used to overexpress or knock down Cav1 expression respectively, in the dorsal striatum. Under a fixed-ratio schedule, LV-Cav1 enhanced and LV-shCav1 reduced responding for methamphetamine in an extended access paradigm compared to LV-GFP controls. LV-Cav1 and LV-shCav1 also produced an upward and downward shift in a dose-response paradigm, generating a drug vulnerable/resistant phenotype. LV-Cav1 and LV-shCav1 did not alter responding for sucrose. Under a progressive-ratio schedule, LV-shCav1 generally reduced positive-reinforcing effects of methamphetamine and sucrose as seen by reduced breakpoints. Western blotting confirmed enhanced Cav1 expression in LV-Cav1 rats and reduced Cav1 expression in LV-shCav1 rats. Electrophysiological findings in LV-GFP rats demonstrated an absence of high-frequency stimulation (HFS)-induced long-term potentiation (LTP) in the dorsal striatum after extended access methamphetamine self-administration, indicating methamphetamine-induced occlusion of plasticity. LV-Cav1 prevented methamphetamine-induced plasticity via increasing phosphorylation of calcium calmodulin kinase II, suggesting a mechanism for addiction vulnerability. LV-shCav1 produced a marked deficit in the ability of HFS to produce LTP and, therefore, extended access methamphetamine was unable to alter striatal plasticity, indicating a mechanism for resistance to addiction-like behavior. Our results demonstrate that Cav1 expression and knockdown driven striatal plasticity assist with modulating addiction to drug and nondrug rewards, and inspire new strategies to reduce psychostimulant addiction. |
